Try methadone first to quit heroin, says expert

26 April 2002

Most heroin users who want to quit should try methadone or buprenorphine first, with naltrexone a second option, according to Australian research, the world's first comparative study of its kind.

The study, which will be presented at the Royal Australasian College of Physicians conference in Brisbane next month, is the first randomised controlled trial to compare a drug that blocks the effects of heroin with a maintenance or substitution therapy.

For 90 per cent [of heroin users who want to quit], I would recommend agonists such as methadone or the partial opioid agonist buprenorphine as first-line treatment, with rapid detoxification with naltrexone a second-stage treatment,' said Brisbane researcher Professor John Saunders.

But the University of Queensland professor of alcohol and drug studies, and director of Royal Brisbane Hospital's alcohol and drug service, said it was important to offer people a range of options.

He said trial participants who stayed on naltrexone had excellent outcomes, with more than 90 per cent of people reducing their heroin use, which was better than those staying on methadone. But the naltrexone attrition rates (people stopping taking it) were significant.

Another reason why methadone should be tried first was because outcomes also depended on whether patients had previously been in treatment. Former methadone users who took naltrexone in the trial had retention rates of 50-60 per cent, compared with 20 per cent for people who had not tried methadone.

 


 
Sponsored links

myDr Newsletter

Get myDr delivered to your inbox Privacy Policy
 
Advertisement
Advertisement

This web site is intended for Australian residents and is not a sbstitute for independent professional advice. Information and interactions contained in ths Web site are for infomation purposes only and are not intended ot be used to diagnose,treat , cure or prevent any disease.Further , the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. MIMS Australia Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incured by use of or relance on the information made available via or throught myDr whether arising from negligence or otherwise.
See Privacy Policy and Disclaimer.